UGPA3 enters the final week of August with an unusual split: a sharp one-day drop contrasting against a month of quiet gains, while short sellers show almost no interest in pressing the bear case.
The most striking data point this week is how reluctant short sellers are to engage. Borrow availability is near 9,500% — meaning for every share currently borrowed, there are roughly 95 more available to lend. That is an exceptionally loose lending market. The ORTEX short score confirms the picture: at 25.3, it has barely moved in weeks, and ranks in the 97th percentile for low short pressure. Days-to-cover ranks in the 96th percentile. Cost to borrow is running at just 0.59% annually, down nearly 20% over the past month, and well below levels seen in mid-2025 when it briefly touched 0.86%. Positioning here looks almost entirely uncrowded from the short side.
The Street appears to agree that Ultrapar deserves a modest premium to current levels. The consensus price target sits at BRL 34.99, around 4% above Tuesday's close of BRL 33.62. No analyst changes have been filed recently. The analyst recommendation differential factor ranks in the 94th percentile — meaning the gap between current price and analyst consensus is wide relative to the broader universe. The EV/EBITDA multiple of 5.9x and a P/E of 12.1x are not demanding for a Brazilian energy distribution and logistics conglomerate. What is less encouraging is the forward earnings trajectory: the 12-month forward EPS growth factor ranks in just the 4th percentile, and 30-day EPS momentum has turned negative. Quality indicators have also softened — the Piotroski F-score dropped from 7 to 5 over the past six months. Bulls point to defensive cash generation from the Ipiranga fuel network and Ultracargo terminals; bears flag deteriorating growth signals and a stock that has faded meaningfully from its January highs.
On the ownership side, the register is stable and dominated by long-term holders. Ultra S.A. Participações holds just over 26% and has not changed its position. BlackRock added roughly 1.6 million shares through July, bringing its stake to 5.7%. Qube Research & Technologies, a quantitative manager, added just over 3 million shares in Q2, a notable move for a name of that size in the stock. Hartford Funds and Bizma Investimentos trimmed, the latter cutting its holding by more than 5 million shares through June. Insider activity has been limited to routine board awards, with no open-market buying or selling of note in the past three months.
The most recent earnings reaction is worth noting. When Ultrapar reported in mid-August, the stock gained 5.8% on the day and 12.6% over the following five sessions — the strongest post-earnings move in the recent history shown here. Tuesday's 3.2% pullback from BRL 34.74 erases a portion of that gain, though the stock is still up around 1% on the week. The closest Bovespa peer, VBBR3, was broadly flat on the week. CSAN3 moved sharply in the opposite direction, gaining nearly 20% over the same period — a divergence worth tracking as a read on whether sector flows are rotating within Brazilian energy distribution names.
The next scheduled earnings event is 11 November. Between now and then, the key variables to watch are whether the recent deterioration in EPS momentum reverses, and whether the analyst consensus — currently the most positive relative to price it has been in some time — begins to attract fresh institutional buying or simply fades with the stock.
See the live data behind this article on ORTEX.
Open UGPA3 on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
